AzTrials
AzTrials

Edema LegBreak_sittingNCT05173558

Breaking of Sitting Time Prevents Lower Leg Swelling

A study testing Uninterrupted motionless standing, Uninterrupted motionless sitting and Sit-to-stand transitions in people with Edema Leg, run by Faculdade de Motricidade Humana at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sitting or standing during a prolonged and uninterrupted period of time is related to negative health outcomes, such as lower extremity swelling. It is unknown if interrupting sedentary behavior by including brief bouts of standing up to the sitting time can attenuate lower leg swelling. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Edema Leg
What is being tested?
Uninterrupted motionless standing, Uninterrupted motionless sitting and Sit-to-stand transitions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 sitePortugal
Study dates
1 Mar 2020to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • BMI ranging between 18.5 to 29.9 kg/m2;
  • Not taking any medications at the time of the measurements;
  • All women should have a (self-reported) regular menstrual cycle.

Who cannot join

  • Self-reported inability to stand for 20min without moving the lower limbs
  • An active smoking status
  • Presence of diabetes

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Faculdade de Motricidade Humana

    Oeiras, Cruz-Quebrada, 1409-002

Other trials in Portugal

About this study

Official title: Breaking of Sitting Time Prevents Lower Leg Swelling - Comparison Among Sit, Stand and Intermittent (Sit-to-stand Transitions) Conditions

Sitting or standing during a prolonged and uninterrupted period of time is related to negative health outcomes, such as lower extremity swelling. It is unknown if interrupting sedentary behavior by including brief bouts of standing up to the sitting time can attenuate lower leg swelling. Thus, our purpose is to examine if breaking sitting time by adding sit-to-stand transitions attenuates or even prevents lower leg swelling, compared with uninterrupted motionless standing and uninterrupted motionless sitting, using localized bioelectrical impedance raw parameters.

Read the detailed description

Increased sedentary behavior has deleterious effects on cognitive function, mental health, physical function, disability as well as quality-of-life. Nowadays, prolonged sitting time has been introduced into many situations such as transportation and in the workplace. Staying in the same position (e.g., sitting/standing) for a long and uninterrupted period is associated with poorer health-outcomes, increasing the risk for premature mortality. For instance, sitting for a long period of time has been associated with lower limbs edema. This condition causes discomfort and pain, in turn associated with a lower quality-of-life.

The literature shows that interruption of prolonged sitting time has a positive impact in several health-related risk factors. However, no studies analyzed the effects of motionless sitting with brief standing bouts on lower leg swelling. Thus, the aim of this study is to examine and to compare the effects of standing, sitting and sit-to-stand transitions on lower leg swelling using localized bioelectrical impedance analysis (BIA) measurements A crossover randomized experiment was performed among 20 healthy individuals [age: 27.5±5.9y, 47% females]. In this study, the participants performed the 3 conditions (randomly ordered): 1) uninterrupted motionless standing; 2) uninterrupted motionless sitting; 3) sit-to-stand transitions (1 minute sitting followed by 1 minute standing). Before each condition, a 10-min resting period was performed. Total fat and fat-free mass were determined by dual-energy x-ray absorptiometry. Localized resistance (R), reactance (Xc), impedance (Z) and phase angle (PhA) were assessed at the baseline, at 10 min and at 20 min for each condition.

The researchers hypothesized that interrupting a prolonged sitting position with sit-to-stand transitions will result in greater muscle pump, preventing lower leg swelling.

Conditions
Edema Leg
Being tested
Uninterrupted motionless standing, Uninterrupted motionless sitting, Sit-to-stand transitions
Keywords
Bioimpedance, Raw BIA parameters, Extracellular water expansion, Sedentary behaviour

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Uninterrupted motionless standingBehavioural

    Participants remained 20 minutes of uninterrupted motionless standing

  • Uninterrupted motionless sittingBehavioural

    Participants remained 20 minutes of uninterrupted motionless sitting

  • Sit-to-stand transitionsBehavioural

    20 minutes of sit-to-stand transitions (1 minute sitting with 1 minute standing)

Study groups in NCT05173558
Study groupRoleWhat they receive
Uninterrupted motionless standingExperimental20minutes of uninterrupted motionless standing
Receives: Behavioral: Uninterrupted motionless standing
Uninterrupted motionless sittingExperimental20 minutes of uninterrupted motionless sitting
Receives: Behavioral: Uninterrupted motionless sitting
Sit-to-stand transitionsExperimental20 minutes of sit-to-stand transitions (1 minute sitting with 1 minute standing)
Receives: Behavioral: Sit-to-stand transitions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Phase Angle (º)

    The bioimpedance AKERN BIA 101/BIVA PRO was used to assess physical parameters. Akern is a phase-sensitive device that measures phase angle (PhA).

    Measured: 8 weeks

  2. Impedance (Ohm)

    The bioimpedance AKERN BIA 101/BIVA PRO was used to assess physical parameters. Akern is a phase-sensitive device that measures impedance (Z).

    Measured: 8 weeks

  3. Resistance (Ohm)

    The bioimpedance AKERN BIA 101/BIVA PRO was used to assess physical parameters. Akern is a phase-sensitive device that measures phase angle (PhA) and impedance (Z), and then calculates resistance (R).

    Measured: 8 weeks

  4. Reactance (Ohm)

    The bioimpedance AKERN BIA 101/BIVA PRO was used to assess physical parameters. Akern is a phase-sensitive device that measures phase angle (PhA) and impedance (Z), and then calculates reactance (Xc).

    Measured: 8 weeks

Secondary outcomes (6)
  1. Fat Free Mass (kg)

    Dual-energy X-ray absorptiometry (DXA; Hologic Explorer-W, Waltham, USA) was used to determine fat-free mass (FFM). A whole-body scan was performed, and the attenuation of X-rays pulsed between 70 and 140kV synchronously with the line frequency for each pixel of the scanned image was measured

    Measured: 8 weeks

  2. Fat mass (kg)

    Dual-energy X-ray absorptiometry (DXA; Hologic Explorer-W, Waltham, USA) was used to determine total fat mass (FM). A whole-body scan was performed, and the attenuation of X-rays pulsed between 70 and 140kV synchronously with the line frequency for each pixel of the scanned image was measured.

    Measured: 8 weeks

  3. Weight (kg)

    Weight was measured in bathing suit and no shoes to the nearest 0.01kg using a weight scale.

    Measured: 8 weeks

  4. Height (cm)

    Height was measured in bathing suit and no shoes to the nearest 0.1cm using a a stadiometer (Seca, Hamburg, Germany), respectively.

    Measured: 8 weeks

  5. Blood pressure (mmHg)

    Blood pressure was measured (seated and bipedal) right before the start of each protocol. During the experimental condition, blood pressure was measured every 5 minutes.

    Measured: 8 weeks

  6. Heart Rate (bpm)

    Heart rate was measured (seated and bipedal) right before the start of each protocol. During the experimental condition, heart rate was measured every 5 minutes.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2021
  2. Study start1 Mar 2020
  3. Primary completion30 Jun 2020
  4. Study completion31 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05173558
Sponsor's protocol ID
Break_Sitt
Acronym
Break_sitting
Status last verified
Jan 2022
First submitted
30 Nov 2021
Last updated
18 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Uninterrupted motionless standing, Uninterrupted motionless sitting and Sit-to-stand transitions in people with Edema Leg, run by Faculdade de Motricidade Humana at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Phase Angle (º) (time frame: 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in